365 related articles for article (PubMed ID: 27983998)
21. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I
Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
[TBL] [Abstract][Full Text] [Related]
22. Role of D-dimer in predicting mortality in patients with community-acquired pneumonia.
Nastasijević Borovac D; Radjenović Petković T; Pejčić T; Stanković I; Janković I; Ćirić Z; Rančić M
Med Glas (Zenica); 2014 Feb; 11(1):37-43. PubMed ID: 24496339
[TBL] [Abstract][Full Text] [Related]
23. A novel biochemical marker for community-acquired pneumonia: Ischemia-modified albumin.
Bolatkale M; Duger M; Ülfer G; Can Ç; Acara AC; Yiğitbaşı T; Seyhan EC; Bulut M
Am J Emerg Med; 2017 Aug; 35(8):1121-1125. PubMed ID: 28302374
[TBL] [Abstract][Full Text] [Related]
24. Cold-inducible RNA-binding protein might determine the severity and the presences of major/minor criteria for severe community-acquired pneumonia and best predicted mortality.
Guo Q; Song WD; Li HY; Li M; Chen XK; Liu H; Peng HL; Yu HQ; Liu N; Lü ZD; Liang LH; Zhao QZ; Jiang M
Respir Res; 2020 Jul; 21(1):192. PubMed ID: 32689999
[TBL] [Abstract][Full Text] [Related]
25. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
[TBL] [Abstract][Full Text] [Related]
27. Tools for outcome prediction in patients with community acquired pneumonia.
Khan F; Owens MB; Restrepo M; Povoa P; Martin-Loeches I
Expert Rev Clin Pharmacol; 2017 Feb; 10(2):201-211. PubMed ID: 27911103
[TBL] [Abstract][Full Text] [Related]
28. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
[TBL] [Abstract][Full Text] [Related]
29. Expression of B and T Lymphocyte Attenuator in Patients with Severe Community-Acquired Pneumonia and the Effect of Steroid Therapy in a Mouse Model.
Zhou G; Wang D; Liu D; Qi D; Liu Z
Clin Lab; 2016 Dec; 62(12):2367-2377. PubMed ID: 28164546
[TBL] [Abstract][Full Text] [Related]
30. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of serum pregnancy-associated plasma protein A level at the initial ED presentation in elderly patients with CAP.
Golcuk Y; Golcuk B; Bilge A; Korkmaz A; Irik M; Hayran M; Ozdemir AT; Kurtulmus Y
Am J Emerg Med; 2015 Sep; 33(9):1232-6. PubMed ID: 26113245
[TBL] [Abstract][Full Text] [Related]
32. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
[TBL] [Abstract][Full Text] [Related]
33. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
[TBL] [Abstract][Full Text] [Related]
34. Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia.
Tsai PK; Tsao SM; Yang WE; Yeh CB; Wang HL; Yang SF
Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30901954
[TBL] [Abstract][Full Text] [Related]
35. Consecutive Measures of CRP Correlate with Length of Hospital Stay in Patients with Community-Acquired Pneumonia.
Farah R; Khamisy-Farah R; Makhoul N
Isr Med Assoc J; 2018 Jun; 20(6):345-348. PubMed ID: 29911753
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil CD11b and soluble ICAM-1 and E-selectin in community acquired pneumonia.
Glynn P; Coakley R; Kilgallen I; O'Neill S
Eur Respir J; 1999 Jun; 13(6):1380-5. PubMed ID: 10445615
[TBL] [Abstract][Full Text] [Related]
37. Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia--a clinical observation in geriatric patients.
Heppner HJ; Bertsch T; Alber B; Esslinger AS; Dragonas C; Bauer JM; Sieber CC
Gerontology; 2010; 56(4):385-9. PubMed ID: 19940454
[TBL] [Abstract][Full Text] [Related]
38. The value of procalcitonin level in community-acquired pneumonia in the ED.
Park JH; Wee JH; Choi SP; Oh SH
Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
[TBL] [Abstract][Full Text] [Related]
39. Initial serum lactate level is associated with inpatient mortality in patients with community-acquired pneumonia.
Gwak MH; Jo S; Jeong T; Lee JB; Jin YH; Yoon J; Park B
Am J Emerg Med; 2015 May; 33(5):685-90. PubMed ID: 25791153
[TBL] [Abstract][Full Text] [Related]
40. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.
Lee JH; Kim J; Kim K; Jo YH; Rhee J; Kim TY; Na SH; Hwang SS
J Crit Care; 2011 Jun; 26(3):287-94. PubMed ID: 21129911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
